Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Novavax, Inc.’s mid-stage trials on a combination of Covid-19 and influenza and a standalone influenza vaccine have been put on hold by the US regulator after a volunteer developed a serious nerve disorder.
The US Food and Drug Administration cleared Novavax’s Covid-19 vaccine, targeting the JN.1 strain, for people 12 years of age and older, according to a statement from the regulator.
The US Food and Drug Administration has granted emergency use authorisation to the Covid-19 vaccine made by Pfizer Inc., and ModernaTX Inc., which incorporates a new component to fight a variant of the virus.
Vaccinations have saved more than 1.6 million lives in the WHO European Region and Covid-19 is lurking around the world menacingly with its new variants, according to the global health agency.
The WHO’s event-based surveillance system has reported that at least 40 athletes participating in the Olympic Games in France had tested positive for Covid-19 or other respiratory illnesses.
The SARS-CoV-2 virus was detected in six backyard species in the southeastern US state of Virginia with unique viral mutations with lineages closely matching variants circulating in humans, according to a study.
The European Medicines Agency has allowed marketing authorisation for the Covid-19 variant vaccine made by Pfizer and BioNTech SE for children aged six months and older, according to a joint statement.
The UN’s Gavi, the Vaccine Alliance, has restored its efforts to prevent and control rabies globally by increasing the availability of vaccines and eliminating the disease by 2030 after Covid-19 disrupted its rollout.
HQ Team May 13, 2024: New research says Covid-19 vaccines given to people suffering from heart failure improve their chances of living longer by 82%. This study was presented at the Heart Failure 2024, a scientific congress of
HQ Team March 20, 2024: The Covid-19 virus can damage the heart, even without directly affecting the heart tissue, according to a study by the National Institutes of Health (NIH). Earlier research on SARS-CoV-2, the virus that causes